SILO PHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.68 USD | -4.55% |
|
-9.19% | +16.67% |
| 04-23 | Silo Pharma, Inc. Announces Positive Results for Intranasal PTSD Treatment | CI |
| 04-10 | Silo Pharma Says It Exercised Option to License Alzheimer's Therapeutic From Columbia University | MT |
Evolution of the average Target Price on Silo Pharma, Inc.
Price target over the last 5 years
History of analyst recommendation changes
94d747535bdda2.zdrR6SYSBHJradsyHNqbVeVKX4M5hFSVTi0juVraF7o.j7DpmFEqY0IOM4l_cb_ILbcNJbNV4CSiemAO2h_jQciklpCuEF1zQAUO7w~772da7c17fbc3ce7902129ed2cf07bb3
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.68
USD
Average target price
10
USD
Spread / Average Target
+495.24%
High Price Target
10
USD
Spread / Highest target
+495.24%
Low Price Target
10
USD
Spread / Lowest Target
+495.24%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Silo Pharma, Inc.
| Laidlaw & Co. |
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- SILO Stock
- Consensus Silo Pharma, Inc.
